24 tabbed for McKnight’s Women of Distinction Hall of Honor
By
Lois A. Bowers
Feb 15, 2024
Twenty-four top women executives have been named 2024 inductees into the McKnight’s Women of Distinction Hall of Honor, organizers announced Thursday.
McKnight’s Women of Distinction Class of 2024 welcomes 15 Rising Stars
By
Lois A. Bowers
Feb 13, 2024
Fifteen “Rising Stars” working in senior living, skilled nursing or home care have been named 2024 McKnight’s Women of Distinction honorees, program organizers announced Tuesday.
The metaverse and its future-forward impact on senior care
By
Melissa Powell
Feb 12, 2024
We’re in the throes of a technological renaissance. Among the innovative tools and devices shaking up industries and leaving consumers and professionals awestruck emerges the metaverse, a fusion...
Clinical briefs for Monday, Feb. 5
By
Kristen Fischer
Feb 05, 2024
Dementia was rare in ancient times … 4 US sites join Parkinson’s disease genetics study… Risvodetinib phase 1 results for Parkinson’s promising … Disparities have a say in stroke recovery …...
Genetics, air pollution can boost Parkinson’s risk, study finds
By
Kristen Fischer
Jan 26, 2024
The idea that air pollution can play a role in the development of Parkinson’s disease has been in the news in recent years, and a new study adds to evidence of the association.
Clinical briefs for Friday, Jan. 26
By
Kristen Fischer
Jan 26, 2024
Exam can spot glaucoma risk in primary angle-closure suspect patients … Heart organization announces $7.8M for “food is medicine” research … Researchers eye gene in heart failure that may guide...
Clinical briefs for Friday, Jan. 19
By
Kristen Fischer
Jan 19, 2024
Large-scale study of those of African descent spots genetic variants tied to glaucoma … Brain stimulation kept quality of life stable after 5 years in people with Alzheimer’s … Insurers must apply...
Race, ethnicity help determine which controllable risk factors for dementia have biggest impacts
By
Kristen Fischer
Jan 18, 2024
Controllable risk factors that factor into Alzheimer’s or dementia cases play varying roles based on someone’s race and ethnicity, a new study shows.
Researchers spot whose cognitive ability may shift during dementia trials
By
Kristen Fischer
Jan 17, 2024
People who changed cognitive status from impaired to normal during clinical trials tend to be younger, have better cognition and be negative for amyloid biomarkers, according to a new study.